Acta Diabetologica

, Volume 48, Issue 4, pp 349–353 | Cite as

Metabolic inflexibility is a common feature of impaired fasting glycaemia and impaired glucose tolerance

Short Communication

Abstract

Metabolic flexibility reflects the ability to switch from lipid to carbohydrate oxidation during insulin stimulation. Impaired metabolic flexibility is related to insulin resistance and type 2 diabetes, but whether metabolic flexibility is impaired in individuals with the pre-diabetic states isolated impaired fasting glycaemia (i-IFG) and isolated impaired glucose tolerance (i-IGT) is unknown. Using the gold standard euglycaemic hyperinsulinaemic clamp technique combined with indirect calorimetry, we measured peripheral insulin sensitivity, lipid and glucose oxidation, and thus metabolic flexibility in 66 individuals with normal glucose tolerance (NGT, n = 20), i-IFG (n = 18) and i-IGT (n = 28). During insulin stimulation, individuals with i-IGT displayed reduced insulin sensitivity including reduced glucose oxidation. Interestingly, those with i-IFG exhibited reduced glucose oxidation and a slightly elevated lipid oxidation rate during insulin infusion despite having normal total peripheral glucose disposal. Thus, metabolic flexibility was significantly reduced in individuals with both i-IFG and i-IGT even after adjustment for BMI and insulin sensitivity. The data indicate that metabolic inflexibility may precede the development of overt peripheral insulin resistance in pre-diabetic individuals. However, prospective studies are needed to confirm this notion.

Keywords

Insulin resistance Impaired fasting glycaemia Impaired glucose tolerance Metabolic flexibility Glucose oxidation Lipid oxidation Non-esterified fatty acids Non-oxidative glucose metabolism 

References

  1. 1.
    Vaag A, Lehtovirta M, Thye-Rönn P, Groop L, Evans J (2001) Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR). Diabet Med 18:533–540PubMedCrossRefGoogle Scholar
  2. 2.
    Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203PubMedCrossRefGoogle Scholar
  3. 3.
    Vaag AA, Handberg A, Skott P, Richter EA, Beck-Nielsen H (1994) Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations. Eur J Endocrinol 130:70–79PubMedCrossRefGoogle Scholar
  4. 4.
    Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight. Diabetes 51:1271–1280PubMedCrossRefGoogle Scholar
  5. 5.
    Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance—results from the veterans administration genetic epidemiology study. Diabetes 55:1430–1435PubMedCrossRefGoogle Scholar
  6. 6.
    Festa A, D’Agostino R, Hanley AJ, Karter AJ, Saad MF, Haffner SM (2004) Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53:1549–1555PubMedCrossRefGoogle Scholar
  7. 7.
    Færch K, Vaag A, Holst J, Glümer C, Pedersen O, Borch-Johnsen K (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51:853–861PubMedCrossRefGoogle Scholar
  8. 8.
    Ruchat SM, Elks CE, Loos RJF et al (2009) Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 46:217–226PubMedCrossRefGoogle Scholar
  9. 9.
    Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677–683PubMedCrossRefGoogle Scholar
  10. 10.
    Kelley DE, Mokan M, Mandarino LJ (1992) Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 41:698–706PubMedCrossRefGoogle Scholar
  11. 11.
    Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. AJP Endocrinol Metab 277:E1130–E1141Google Scholar
  12. 12.
    Galgani JE, Heilbronn LK, Azuma K et al (2008) Metabolic flexibility in response to glucose is not impaired in people with Type 2 diabetes after controlling for glucose disposal rate. Diabetes 57:841–845PubMedCrossRefGoogle Scholar
  13. 13.
    Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Charlotta P (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prev Rehab 10:377–386CrossRefGoogle Scholar
  14. 14.
    DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395PubMedCrossRefGoogle Scholar
  15. 15.
    Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213PubMedCrossRefGoogle Scholar
  16. 16.
    Felber JP, Ferrannini E, Golay A et al (1987) Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341–1350PubMedCrossRefGoogle Scholar
  17. 17.
    Corpeleijn E, Mensink M, Kooi ME, Roekaerts PMHJ, Saris WHM, Blaak EE (2008) Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity 16:1025–1032PubMedCrossRefGoogle Scholar
  18. 18.
    Storlien L, Oakes ND, Kelley DE (2004) Symposium 6: adipose tissue-liver-muscle interactions leading to insulin resistance—metabolic flexibility. Proc Nutr Soc 63:363–368PubMedCrossRefGoogle Scholar
  19. 19.
    Abdul-Ghani MA, Molina-Carrion M, Jani R, Jenkinson C, DeFronzo R (2008) Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta Diabetol 45:147–150PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Steno Diabetes CenterGentofteDenmark

Personalised recommendations